Beta2 Agonist Therapy: Oral Versus Inhaled Delivery
- 1 January 1992
- journal article
- research article
- Published by Taylor & Francis in Journal of Asthma
- Vol. 29 (1), 49-54
- https://doi.org/10.3109/02770909209110640
Abstract
Although there is a place for administering oral medication, the inhaled route of administration for both bronchodilator and prophylactic purposes has been definitely shown to be the preferred route in numerous studies. The rapid onset of action, equivalent activity, and reduction in systemic effects all should lead the clinician to this form of therapy. Care must be taken to ensure proper utilization of the different types of inhalational medication to optimize their effectiveness.Keywords
This publication has 9 references indexed in Scilit:
- Addition of Terbutaline to Optimal Theophylline TherapyChest, 1986
- Bronchodilator and Side Effects of Different Modes of Administration of Metaproterenol: Inhaled, Oral, and in CombinationThe Lancet Healthy Longevity, 1986
- Bronchodilatory Effect of Inhaled versus Oral Salbutamol in Bronchial AsthmaRespiration, 1983
- A comparison of the effects of different methods of administration of β-2-sympathomimetics in patients with asthmaRespiratory Medicine, 1982
- Do oral and inhaled terbutaline have different effects on the lung?Respiratory Medicine, 1982
- Bronchial Response to Oral Versus Aerosol Metaproterenol in AsthmaAnnals of Internal Medicine, 1980
- Bronchodilator Effects of Terbutaline and Aminophylline Alone and in Combination in Asthmatic PatientsNew England Journal of Medicine, 1978
- Intravenous or inhaled salbutamol in severe acute asthma?Thorax, 1977
- Letter: Death in asthma.BMJ, 1975